Tag Archives: European Parliament

Europe: EFPIA Campaign Calls for Integrated Life Sciences Strategy

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has launched a social media campaign calling for an integrated life sciences  strategy for the EU. The #HealthyEU Health and Growth campaign will outline the opportunities and threats faced by patients and the healthcare sector today, and provide evidence and facts to inform healthcare debates in the run […]
Posted in E-Media, Europe, Events, Global, multimedia, Regulatory, social media, Strategy | Also tagged , , , , | Leave a comment

Europe: Whatever Happened to Faster Reimbursement for Generics?

The plan to accelerate generic pricing and reimbursement has become another tragic European casualty, writes Brussels correspondent Reflector.
Posted in Europe, Op-Ed, pricing, Regulatory | Also tagged , , , , | Leave a comment

EU Clinical Trials Rules: One Step Closer But Not Yet a Done Deal

By Peter O’ Donnell. To believe the European Parliament, the battle to create new clinical trials rules for the European Union is over. On January 22, the parliament’s health committee adopted the draft report prepared last year by one of its leading members. “Clearer rules, better protection for patients,” trumpeted the parliament’s press machine after […]
Posted in Europe, Global, Guest Blog, R&D, Regulatory | Also tagged , , , | Leave a comment

The European Regulatory Outlook for 2014

Pharm Exec’s EU correspondent, Reflector, looks at some of the European regulatory developments earmarked for 2014 and anticipates their effect on the industry. Personnel Some of the big influences on the pharma industry in Europe next year — and for several years to come — will be the big changes upcoming in key personnel in […]
Posted in Europe, Global, healthcare, R&D, Regulatory | Also tagged , , , , , , , , | Leave a comment

No Rapid European Turn-Around at the Turn of the Year

By Peter O’ Donnell. It is not only the specific issue of clinical trials rules that hangs in the balance as Europe shifts from 2013 to 2014. Many of the outstanding questions about the European Union’s attempt to update its rules will not be answered until the European Parliament finds time in the new year to […]
Posted in Europe, Guest Blog, healthcare, Regulatory | Also tagged , , , | Leave a comment
  • Categories

  • Meta